Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Fr Ophtalmol ; 43(1): 43-50, 2020 Jan.
Artigo em Francês | MEDLINE | ID: mdl-31870667

RESUMO

PURPOSE: To evaluate anatomical and functional outcomes of surgical displacement of macular hemorrhages complicating exsudative age-related macular degeneration (AMD) after vitrectomy, subretinal rtPA (recombinant tissue plasminogen activator) injection, intravitreal bevacizumab injection and gaz tamponade. METHODS: Retrospective case series, including 26 patients with submacular hemorrhage, who underwent a surgical displacement within 15 days after the onset of symptoms. Optical coherence tomography (OCT) was carried out to measure the diameter of the hemorrhage and to specify the relation with retinal pigment epithelium. Anatomical success was defined as a total displacement of the hemorrhage away from the fovea at first postoperative visit. Visual acuity improvement was measured at 1 and 6 months and at final postoperative visit. RESULTS: The procedure resulted in hemorrhage displacement away from the fovea in 20 eyes (81%). Visual acuity significantly improved by 5,8 (±7,2) lines (P=0.0003) at 1 month postoperatively, 7,4 (±6,7) lines (P=0.0004) at 6 months and 7,4 (±7,4) lines (P=0.0002) at final postoperative visit (16,5±19,8 months). There was an inverse correlation between hemorrhage diameter and final acuity improvement (Pearson correlation coefficient P=-0.60 (IC 95% [-0.81; -0.26]; P=0.002)). CONCLUSION: Vitrectomy with subretinal rtPA injection was found to be effective for the displacement of AMD hemorrhage in 81 % of the patients. Mean final visual acuity improved by more than 7 lines.


Assuntos
Hematoma/terapia , Degeneração Macular/terapia , Hemorragia Retiniana/terapia , Ativador de Plasminogênio Tecidual/administração & dosagem , Vitrectomia , Idoso , Idoso de 80 Anos ou mais , Bevacizumab/administração & dosagem , Bevacizumab/efeitos adversos , Terapia Combinada , Feminino , Hematoma/complicações , Hematoma/tratamento farmacológico , Hematoma/cirurgia , Humanos , Injeções Intraoculares , Degeneração Macular/complicações , Degeneração Macular/tratamento farmacológico , Degeneração Macular/cirurgia , Masculino , Dados Preliminares , Proteínas Recombinantes/administração & dosagem , Proteínas Recombinantes/efeitos adversos , Hemorragia Retiniana/complicações , Hemorragia Retiniana/tratamento farmacológico , Hemorragia Retiniana/cirurgia , Estudos Retrospectivos , Ativador de Plasminogênio Tecidual/efeitos adversos , Resultado do Tratamento , Vitrectomia/efeitos adversos , Vitrectomia/métodos
2.
J Fr Ophtalmol ; 42(9): e391-e397, 2019 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-31471124

RESUMO

INTRODUCTION: Macular subretinal hematoma is a complication of age related macular degeneration (AMD) responsible for a severe change in vision. We evaluated anatomic and functional results of surgical treatment of hematoma by vitrectomy, subretinal injection of r-tPA (recombinant tissue plasminogen activator), intravitreal bevacizumab injection and air tamponade. METHODS: Retrospective case series including 26 patients with submacular hemorrhage who underwent vitrectomy within 15 days after the onset of symptoms. Optical coherence tomography (OCT) was performed to measure the diameter of the hemorrhage and specify the location in relation to the retinal pigment epithelium. Anatomical success was defined as a total displacement of the hemorrhage out of the fovea at the first postoperative visit. Visual acuity improvement was measured at 1 and 6 months and at final postoperative visit. RESULTS: The procedure resulted in hemorrhage displacement away from the fovea in 20 eyes (81%). Visual acuity significantly improved by 5.8 (±7.2) lines (P=0.0003) at 1 month postoperatively, 7.4 (±6.7) lines (P=0.0004) at 6 months and 7.4 (±7.4) lines (P=0.0002) at the final postoperative visit (16.5±19.8 months). There was an inverse correlation between hemorrhage diameter and final acuity improvement (Pearson correlation coefficient ρ=-0.60 (IC 95% [-0.81; -0.26]; P=0.002)). CONCLUSION: Vitrectomy with subretinal r-tPA injection was found to be effective for the displacement of AMD hemorrhage in 81% of the patients. Mean final visual acuity improved by more than 7 lines, confirming the efficacy and functional benefit of surgical displacement.


Assuntos
Hematoma/etiologia , Hematoma/terapia , Degeneração Macular/complicações , Hemorragia Retiniana/etiologia , Hemorragia Retiniana/terapia , Ativador de Plasminogênio Tecidual/administração & dosagem , Vitrectomia , Idoso , Idoso de 80 Anos ou mais , Terapia Combinada , Feminino , Humanos , Injeções Intralesionais , Degeneração Macular/fisiopatologia , Masculino , Proteínas Recombinantes/administração & dosagem , Recuperação de Função Fisiológica , Retina , Estudos Retrospectivos , Resultado do Tratamento , Acuidade Visual
4.
J Fr Ophtalmol ; 40(9): 744-750, 2017 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-29050928

RESUMO

PURPOSE: To compare the impact of two phacoemulsification techniques (subluxation versus divide-and-conquer) on postoperative corneal edema at postoperative hour 1 and day 4. DESIGN: Comparative study. METHOD: Ninety-six consecutive patients (110 eyes; 43 men and 53 women, mean age 70.9±9.8 years) with equivalent cataract grades underwent cataract surgery and were followed up for 6 months. The presence of corneal edema was determined using central corneal thickness (CCT). CCT was measured preoperatively, and at postoperative hour 1 and day 4. MAIN OUTCOME MEASURES: Ultrasound power (US %), duration of ultrasound (TPA), effective ultrasound time (TPE), surgical duration and final suture (%). RESULTS: Eyes of participants were divided into two phacoemulsification technique groups: subluxation (n=50 eyes) and divide-and-conquer (n=60 eyes). Non-inferiority analysis revealed similar CCT increases at postoperative hour 1 in both groups, with 69.9±44.9µm and 64.4±42.9µm, observed in the subluxation and divide-and-conquer groups, respectively (P=0.033). TPE was similar in both groups, taking 6.2±3.4 and 7.3±4.5seconds in the subluxation and divide-and-conquer groups, respectively (P=0.150). No correlation was seen between TPE and edema at postoperative hour 1, or between TPE and day 4 edema. Rate of final suture use was similar between the subluxation and divide and conquer groups, at 36% and 30%, respectively. CONCLUSION: The study findings suggest that cataract surgery performed using the subluxation technique does not result in greater CCT than the divide-and-conquer technique. CCT appears to normalize by postoperative day 4, regardless of the technique used.


Assuntos
Paquimetria Corneana , Facoemulsificação/efeitos adversos , Facoemulsificação/métodos , Complicações Pós-Operatórias/diagnóstico , Idoso , Idoso de 80 Anos ou mais , Extração de Catarata/efeitos adversos , Extração de Catarata/métodos , Córnea/diagnóstico por imagem , Córnea/fisiopatologia , Córnea/cirurgia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias/etiologia , Período Pós-Operatório , Acuidade Visual
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...